Type 2 diabetes mellitus
Conditions
Interventions
control group:placebo
Sponsors
Dongzhimen Hospital, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Aged 18-65 years; 2.Diabetic patients with stable blood glucose (fasting blood glucose < 7mmol/L, postpranational blood glucose < 10mmol/L) after basic medication; 3.Those who are willing to participate in this study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with serious heart, liver, kidney or other complications or with severe onset disease, mental illness; 2. Pregnant or lactating women; 3. People who cannot cooperate with the diet control or does not use the medicine according to the regulation and affects the curative effect; 4. Inflammatory bowel disease; 5. Recent users of antibiotics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting C-peptide;Fasting insulin;Fasting blood glucose;HbA1c; | — |
Secondary
| Measure | Time frame |
|---|---|
| TNF-a;Intestinal flora;IL-6; | — |
Countries
CHINA
Contacts
Public ContactFu Qiang
Dongzhimen Hospital, Beijing University of Chinese Medicine
Outcome results
None listed